Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-24

Clinical Trial Update: Clinical Efficacy and Safety of MB LuxuryⓇ Product Containing Epigallocathecin Gallate (EGCG) on Erythema, Melanin, and Skin Hydration [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial updates for MB Luxury product containing EGCG evaluating efficacy on hyperpigmentation, erythema, and skin hydration with completed status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MB Luxury Product containing Epigallocathecin Gallate (EGCG) (epigallocatechin gallate)

Snippet

Sponsor: Naniek Widyaningrum | Conditions: Hyperpigmentation, Dry Skin | Phase 2, Phase 3 | Status: COMPLETED